PenderFund Capital Management Ltd.

Position in LSTA — Lisata Therapeutics, Inc.

CIK 1706164 VANCOUVER, A1

Position in LSTA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$237,975

New position

Shares Held

47,500

first reported quarter

Ownership

0.527%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PenderFund Capital Management Ltd. holds $1,699,256 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	MRVI	Maravai Lifesciences Holdings, Inc.	205,000	$1,279,200
2	XENE	Xenon Pharmaceuticals Inc.	6,850	$413,466
3	RNA	Atrium Therapeutics, Inc.	490	$6,590
4			17,800	$0
5			5,200	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$237,975	47,500	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.